Cellular & Molecular Immunology, Published online: 30 July 2026; doi:10.1038/s41423-026-01455-2Platelet-derived serotonin epigenetically programs macrophage alternative activation to orchestrate type 2 airway inflammation
Cellular & Molecular Immunology, Published online: 29 July 2026; doi:10.1038/s41423-026-01453-4NLRC3 enhances antitumor immunity by specifically negatively regulating M-MDSCs in a STING-dependent manner
Cellular & Molecular Immunology, Published online: 29 July 2026; doi:10.1038/s41423-026-01452-5Tumor cell-released autophagosome (TRAP) programs inflammatory CAFs to drive the immune-excluded TIME through C3a
Cellular & Molecular Immunology, Published online: 17 July 2026; doi:10.1038/s41423-026-01451-6The Parkinson’s disease-linked G2019S mutation of LRRK2 increases NADPH oxidase-2 activity in neutrophils for superior control of bacter…
Cellular & Molecular Immunology, Published online: 17 July 2026; doi:10.1038/s41423-026-01449-0Author Correction: DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury
Cellular & Molecular Immunology, Published online: 13 July 2026; doi:10.1038/s41423-026-01450-7Macrophage CCRL2 promotes NLRP3 inflammasome activation to exacerbate atherosclerosis
Cellular & Molecular Immunology, Published online: 13 July 2026; doi:10.1038/s41423-026-01448-1Unifying the hallmarks of major depression through neuroimmune–metabolic–oxidative (NIMETOX) dysregulation: a mechanistic systems framew…
Cellular & Molecular Immunology, Published online: 01 July 2026; doi:10.1038/s41423-026-01439-2FAM234A acts as a switch between Th17 and Treg cell fate decisions that control inflammatory bowel disease
Cellular & Molecular Immunology, Published online: 01 July 2026; doi:10.1038/s41423-026-01446-3Targeting SPP1 requires moving beyond ligand blockade
Cellular & Molecular Immunology, Published online: 25 June 2026; doi:10.1038/s41423-026-01445-4USP9X trims STAT1 to curb oncostatin M activity and intestinal inflammation
